The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
The BioNTech SE ADR BNTX inched 0.42% higher to $115.79 Friday, on what proved to be an all-around great trading session for ...
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
BioNTech has entered into two separate settlement agreements with the U.S. National Institutes of Health and the University ...
Seeking Alpha on MSN9d
BioNTech inks $1B settlements with NIH and Penn to resolve COVID vaccine royalty claimsBioNTech (BNTX) stock slipped after signing $1B deals with NIH and the University of Pennsylvania to resolve COVID vaccine ...
DPA International on MSN9d
BioNTech and Pfizer to pay Covid-19 vaccine settlements in USThe German pharmaceutical company BioNTech announced on Friday that it has reached settlements in the US to resolve a ...
Big moves are shaking up BioNTech (NASDAQ:BNTX) this week, and investors are taking notice. The German biotech heavyweight ...
German pharmaceutical company BioNTech has agreed to pay a combined sum of more than $1.2 billion to resolve separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback